Vaccine Development Services
Comprehensive Vaccine Development Support from Discovery to IND
Developing safe and effective vaccines requires a thorough understanding of immune responses, safety profiles, biodistribution, and product characterization throughout preclinical development. Whether advancing traditional or next-generation vaccine platforms, sponsors need reliable data to support regulatory submissions and informed development decisions.
WuXi Biology and Testing provides integrated vaccine development services designed to help biopharmaceutical companies efficiently progress vaccine candidates toward clinical studies. Our multidisciplinary teams combine pharmacology, bioanalytical, DMPK, toxicology, pathology, and regulatory expertise to generate high-quality data supporting vaccine development across diverse modalities and therapeutic areas.
Why Preclinical Vaccine Testing Matters
Successful vaccine development depends on generating robust evidence that demonstrates both safety and immune protection before entering human clinical trials. Preclinical studies help characterize immune responses, optimize dosing strategies, evaluate toxicity, assess biodistribution, and identify potential safety concerns early in development.
As vaccine technologies continue to evolve—including mRNA, viral vector, therapeutic cancer vaccines, and personalized immunotherapies—preclinical testing strategies must also adapt. Selecting appropriate animal models, immunological assays, and safety endpoints is critical for reducing development risk and supporting regulatory expectations.
Capabilities
Safety Assessment for Vaccine Development
Comprehensive toxicology studies evaluate local tolerance, systemic toxicity, repeat-dose safety, and target organ effects. Our toxicology teams design studies appropriate for each vaccine platform while meeting global regulatory expectations.
Vaccine Immunogenicity Testing
Reliable vaccine immunogenicity assessment is essential for understanding immune activation and biological activity. We develop and validate assays to measure binding antibody responses, neutralizing antibodies, cellular immune responses, cytokine profiling, biomarker analysis, and anti-drug antibodies when applicable.
Bioanalytical and Biomarker Support
Our bioanalytical laboratories support vaccine programs through method development, validation, ligand binding assays, LC-MS/MS, biomarker analysis, and immunological assay development.
Pathology and Histopathology
Experienced veterinary pathologists evaluate tissues to characterize vaccine-related findings, inflammatory responses, target organ effects, and correlate pathology with immunological endpoints.
Regulatory Data Packages
Integrated reporting supports regulatory submissions by combining pharmacology, toxicology, pathology, and bioanalytical data into comprehensive packages that facilitate IND and global regulatory filings.
Related Services
Discovery Biology
Advance vaccine candidates with integrated discovery biology capabilities.
Learn More
DMPK
Support novel vaccine platforms with biodistribution, PK, and related analytical studies where applicable.
Learn More
Bioanalysis
Characterize immune responses with validated ligand binding assays, biomarker analysis, and quantitative bioanalysis.
Learn More
Safety Assessment
Evaluate vaccine safety through GLP toxicology, repeat-dose studies, local tolerance, and pathology.
Learn More
You May Also Be Interested In
Discuss Your Program with Us
Share your development goals and key challenges with our experts to define the right path forward.
Frequently Asked Questions
Vaccine development is the process of discovering, optimizing, testing, and manufacturing vaccines that safely stimulate protective immune responses against infectious diseases or other therapeutic targets. Preclinical studies generate critical safety, immunogenicity, and efficacy data before clinical trials begin.
The typical stages include:
- Discovery and antigen selection
- Vaccine design and optimization
- Preclinical testing
- IND or CTA submission
- Clinical development
- Regulatory approval
- Commercial manufacturing
Preclinical testing evaluates vaccine safety, immune responses, dosing strategies, biodistribution, and biological activity before first-in-human studies. These data help reduce development risk and support regulatory submissions.
Our teams support a broad range of vaccine platforms, including recombinant proteins, peptides, viral vectors, DNA vaccines, RNA vaccines, bacterial vaccines, live attenuated vaccines, inactivated vaccines, conjugate vaccines, and emerging therapeutic vaccine technologies.
Yes. We support both prophylactic and therapeutic vaccines, including oncology and immunotherapy programs, through integrated pharmacology, bioanalysis, toxicology, pathology, and regulatory testing services.